Mechanistically, miR‐503 co‐targeted VEGFA and FGFR1, and then blocked the MAPK/ERK pathway, thus alleviating silica‐induced pulmonary fibrosis (Figure 6). The gene discussed is VEGFA; the disease is pulmonary fibrosis.